Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 526 AL 540

Potential Protein Blood-based Biomarkers in Different Types of Dementia: A Therapeutic Overview

Manzine PR, Vatanabe IP, Grigoli MM, Pedroso RV, Monteiro MPAO, Oliveira DSMS, Nascimento CMC, Peron R, Orlandi FS, Cominetti MR.

Curr Pharm Des. 2022;28(14):1170-1186. doi: 10.2174/1381612828666220408124809.

Influencing factors and characterization methods of nanoparticles regulating amyloid aggregation

Li L, Liu J, Li X, Tang Y, Shi C, Zhang X, Cui Y, Wang L, Xu W.

Soft Matter. 2022 May 4;18(17):3278-3290. doi: 10.1039/d1sm01704g.

Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease

Yu QY, Ye LQ, Li HL.

Neurochem Int. 2022 Jul;157:105342. doi: 10.1016/j.neuint.2022.105342. Epub 2022 Apr 21.

Targeting Insulin-Like Growth Factor-I in Management of Neurological Disorders

Makkar R, Behl T, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Meraya AM.

Neurotox Res. 2022 Jun;40(3):874-883. doi: 10.1007/s12640-022-00513-7. Epub 2022 Apr 27.

Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer's Disease

Merighi S, Borea PA, Varani K, Vincenzi F, Travagli A, Nigro M, Pasquini S, Suresh RR, Kim SW, Volkow ND, Jacobson KA, Gessi S.

Molecules. 2022 Apr 21;27(9):2680. doi: 10.3390/molecules27092680.

The role of basket trials in drug development for neurodegenerative disorders

Cummings J, Montes A, Kamboj S, Cacho JF.

Alzheimers Res Ther. 2022 May 25;14(1):73. doi: 10.1186/s13195-022-01015-6.

Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

Zhang J, Yang T, Huang W, Yu Y, Sun T.

Curr Med Chem. 2022;29(39):6063-6083. doi: 10.2174/0929867329666220527121943.

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review

Mahapatra MK, Karuppasamy M, Sahoo BM.

Pharm Res. 2022 Jun;39(6):1233-1248. doi: 10.1007/s11095-022-03302-1. Epub 2022 Jun 1.

Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation

Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M.

Drug Discov Today. 2022 Oct;27(10):103305. doi: 10.1016/j.drudis.2022.06.005. Epub 2022 Jun 18.

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Fan Y, Chen Z, Zhang M.

J Transl Med. 2022 Jun 27;20(1):291. doi: 10.1186/s12967-022-03493-6.

Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease

Khezri MR, Ghasemnejad-Berenji M.

Neurochem Res. 2022 Oct;47(10):2954-2962. doi: 10.1007/s11064-022-03667-0. Epub 2022 Jul 8.

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight

Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A.

Cells. 2022 Jun 25;11(13):2023. doi: 10.3390/cells11132023.

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside

Basile MS, Bramanti P, Mazzon E.

Molecules. 2022 Jul 21;27(14):4644. doi: 10.3390/molecules27144644.

Targeting endoplasmic reticulum stress using natural products in neurological disorders

Jangra A, Verma M, Kumar D, Chandrika, Rachamalla M, Dey A, Dua K, Jha SK, Ojha S, Alexiou A, Kumar D, Jha NK.

Neurosci Biobehav Rev. 2022 Oct;141:104818. doi: 10.1016/j.neubiorev.2022.104818. Epub 2022 Aug 5.

Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review

Aborode AT, Pustake M, Awuah WA, Alwerdani M, Shah P, Yarlagadda R, Ahmad S, Silva Correia IF, Chandra A, Nansubuga EP, Abdul-Rahman T, Mehta A, Ali O, Amaka SO, Zuñiga YMH, Shkodina AD, Inya OC, Shen B, Alexiou A.

Oxid Med Cell Longev. 2022 Jul 31;2022:7934442. doi: 10.1155/2022/7934442. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias